Biotechrabbit

Biotechrabbit

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $20M

Overview

Biotechrabbit is an established, privately-held life science tools and services company with over three decades of operation. It has built a diversified portfolio spanning PCR reagents, nucleic acid purification, proteomics tools, and antibody services, catering primarily to research and diagnostic markets. The company emphasizes quality, customization, and partnership, holding ISO 13485 and ISO 9001 certifications, which positions it as a qualified supplier for regulated applications. Its business model is focused on providing products and contract services rather than developing its own therapeutic pipeline.

Antibodies

Technology Platform

Integrated capabilities in molecular biology and protein biochemistry reagent manufacturing, including enzyme production, custom antibody development, protein purification tools, and cell-free protein synthesis systems.

Funding History

2
Total raised:$20M
Series A$15M
Seed$5M

Opportunities

Growth in molecular diagnostics and the trend of outsourcing reagent production by IVD companies create significant demand for their certified OEM services.
Geographic expansion into high-growth markets like Asia and North America, evidenced by their conference participation, presents a clear avenue for new customer acquisition.

Risk Factors

The company faces intense competition from global life science tools giants and risks associated with potential customer concentration on a few large OEM partners.
Disruptions in the supply chain for biological raw materials and the need to continuously adapt to new technological methods in molecular biology also pose significant challenges.

Competitive Landscape

Biotechrabbit competes in a fragmented but crowded market dominated by large multinational corporations like Thermo Fisher Scientific, Merck, and Qiagen. Its competitive advantage lies in its specialization, flexibility for customization, high-quality certifications (ISO 13485), and direct service model, targeting customers who may be underserved by the one-size-fits-all approach of larger players.